PERSPECTA

News from every angle

← Back to headlines

Eli Lilly's Taltz-Zepbound Combo Shows Breakthrough in Psoriasis-Obesity Trial

Eli Lilly has announced a landmark trial demonstrating a major breakthrough with its Taltz-Zepbound drug combination for treating both psoriasis and obesity.

21 Feb, 17:31 — 21 Feb, 17:31
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual50d ago

Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo

Read full article →

Related Stories

Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory

just now

Padel for Parkinson’s Cycling Event Held at University of Ghana for Awareness

9m ago

Understanding and Managing Postpartum Sweating

20m ago

Protecting Dogs from Viper Bites as Weather Warms

33m ago